arginine and Blast Phase

arginine has been researched along with Blast Phase in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adamsky, K; Amariglio, N; Ashur-Fabian, O; Cohen, Y; Hardan, I; Nagler, A; Raanani, P; Rechavi, G; Trakhtenbrot, L	1
Dahl, GV; Grier, HE; Kalwinsky, DK; Mason, C; Mirro, J; Murphy, SB; Santana, VM	1

Other Studies

2 other study(ies) available for arginine and Blast Phase

Article	Year
Apaf1 in chronic myelogenous leukemia (CML) progression: reduced Apaf1 expression is correlated with a H179R p53 mutation during clinical blast crisis. Cell cycle (Georgetown, Tex.), 2007, Mar-01, Volume: 6, Issue:5 Topics: Apoptotic Protease-Activating Factor 1; Arginine; Blast Crisis; Gene Expression Regulation, Leukemic; Histidine; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Point Mutation; Tumor Suppressor Protein p53	2007
Effective reinduction therapy for childhood acute nonlymphoid leukemia using simultaneous continuous infusions of teniposide and amsacrine. Cancer chemotherapy and pharmacology, 1989, Volume: 24, Issue:2 Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Infusions, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Leukopenia; Male; Mouth Mucosa; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Stomatitis; Teniposide; Thrombocytopenia	1989

Article

Year

Apaf1 in chronic myelogenous leukemia (CML) progression: reduced Apaf1 expression is correlated with a H179R p53 mutation during clinical blast crisis.

Cell cycle (Georgetown, Tex.), 2007, Mar-01, Volume: 6, Issue:5

Topics: Apoptotic Protease-Activating Factor 1; Arginine; Blast Crisis; Gene Expression Regulation, Leukemic; Histidine; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Point Mutation; Tumor Suppressor Protein p53

2007

Effective reinduction therapy for childhood acute nonlymphoid leukemia using simultaneous continuous infusions of teniposide and amsacrine.

Cancer chemotherapy and pharmacology, 1989, Volume: 24, Issue:2

Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Infusions, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Leukopenia; Male; Mouth Mucosa; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Stomatitis; Teniposide; Thrombocytopenia

1989